Copenhagen, Denmark

Kristian Norup Koch

USPTO Granted Patents = 11 


Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 51(Granted Patents)


Location History:

  • Köbenhavn Ö, DK (2005 - 2007)
  • Köbenhavn, DK (2007)
  • Köbenhaven Ö, DK (2007)
  • Copenhagen, DE (2009)
  • Munich, DE (2009)
  • Copenhagen, DK (2007 - 2016)

Company Filing History:


Years Active: 2005-2016

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Exploring the Innovative Mind of Kristian Norup Koch

Introduction:

In the world of innovations and patents, Kristian Norup Koch from Copenhagen, DK stands out with his impressive contributions in the field. With a total of 11 patents to his name, he has made substantial advancements in the development of muscarinic receptor agonists. Let's delve into his latest patents, career highlights, and notable collaborations.

Latest Patents:

Koch's most recent patents revolve around tetrahydroquinoline analogues as muscarinic agonists. These compounds not only act as muscarinic receptor agonists but also hold potential for inhibiting muscarinic receptor activity, treating disease conditions associated with muscarinic receptors, and identifying suitable subjects for treatment. Through innovative compositions and intricate methods, Koch's inventions aim to foster advancements in the field of pharmacology.

Career Highlights:

Currently affiliated with Acadia Pharmaceuticals Inc., Koch has made significant strides in his professional journey. Acadia Pharmaceuticals Inc. is renowned for its commitment to developing innovative therapies to address unmet medical needs in central nervous system disorders. Koch's contributions align closely with the company's mission, making him an invaluable asset to the team.

Collaborations:

Koch's work has not been accomplished in isolation, as collaborations play a significant role in fostering innovation. Notable coworkers include Bo-Ragnar Tolf and Bo Lennart Mikael Friberg, who have joined forces with Koch to contribute to the advancement of muscarinic receptor agonists and related therapies. Their combined expertise and shared dedication to scientific progress have undoubtedly yielded fruitful outcomes.

Conclusion:

Kristian Norup Koch's groundbreaking patents and contributions in the realm of muscarinic receptor agonists have undoubtedly made a significant impact on the field of pharmacology. With his extensive career highlights and notable collaborations, Koch exemplifies the innovative spirit that drives progress in the healthcare industry. Keeping an eye on Koch's future endeavors promises to be exciting, as he continues to push the boundaries of medical innovation.

For more information on the latest inventions, patents, and groundbreaking innovators like Kristian Norup Koch, visit us at idiyas.com, your ultimate resource for all things related to innovations and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…